Related Articles
EFFECTS OF SUBCUTANEOUS RECOMBINANT IL-2 ON HUMORAL IMMUNITY IN ADVANCED CANCER-PATIENTS
COMBINED INTERLEUKIN-2 AND OKT3 THERAPY IN THE TREATMENT OF METASTATIC MELANOMA
Recombinant interleukin-2 stimulates lymphocyte recovery in patients with severe COVID-19
Impact of the histone deacetylase inhibitor 4-phenylbutyrate on the clearance of apoptotic pancreatic carcinoma cells by human macrophages
SUBCUTANEOUS RIL-2 IN ADVANCED MELANOMA AND KIDNEY CARCINOMA